Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state.

The objective of this study was to characterize the pharmacokinetic parameters and penetration of fluconazole following a single dose in the serum, aqueous humor, vitreous humor and cerebrospinal fluid (CSF) of non pigmented rabbits using serial sampling techniques and to determine if the pharmacokinetic parameters in the eye and CSF are similar. Twenty healthy male rabbits received intravenous fluconazole 20 mg/kg as a single dose or 20 mg/kg every 12 hours for 4 doses. Serum, aqueous humor, vitreous humor and CSF samples were taken 15 minutes after the initial intravenous injection and hourly thereafter for six hours. Fluconazole concentrations were determined by microbiological assay. Pharmacokinetic analyses were performed using a nonlinear least-square regression program. Fluconazole's penetration in all anatomical compartments was > 70% than in the serum. Similar elimination half-lives and time to reach maximum concentrations were noted in all compartments. While mean concentrations in each anatomical compartment were similar in animals receiving a single dose or among those at serum steady state, the mean concentrations achieved in the serum, aqueous and vitreous humors and CSF were between 1.82 and 2.17 times higher at serum steady state than following a single dose. At serum concentrations that are comparable to those in humans, the penetration of fluconazole into the noninflamed aqueous and vitreous humors and CSF were > or = 70%. The CSF and ocular pharmacokinetic parameters closely resembled each other, so that either could be used as a surrogate for the other.

[1]  G. Drusano,et al.  Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program , 1995, Antimicrobial agents and chemotherapy.

[2]  B. Kubak,et al.  Treatment of ocular fungal infections with oral fluconazole. , 1995, American journal of ophthalmology.

[3]  D. D’Amico,et al.  Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole , 1995, Antimicrobial agents and chemotherapy.

[4]  M. Burroughs,et al.  Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid , 1994, Antimicrobial Agents and Chemotherapy.

[5]  J. H. Elliott,et al.  Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B. , 1993, Archives of ophthalmology.

[6]  L. Laatikainen,et al.  Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy. , 1992, American journal of ophthalmology.

[7]  A. Madu,et al.  Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits , 1992, Antimicrobial Agents and Chemotherapy.

[8]  M. Motyl,et al.  Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits , 1991, Antimicrobial Agents and Chemotherapy.

[9]  S. Filler,et al.  Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits , 1991, Antimicrobial Agents and Chemotherapy.

[10]  S. Piscitelli,et al.  Fluconazole: A New Triazole Antifungal Agent , 1990, DICP : the annals of pharmacotherapy.

[11]  I. Fong,et al.  Pharmacokinetics of Fluconazole in Serum and Cerebrospinal Fluid in a Patient with AIDS and Cryptococcal Meningitis , 1990, Pharmacotherapy.

[12]  W. S. Head,et al.  Ocular uptake of fluconazole following oral administration. , 1990, Archives of ophthalmology.

[13]  P. Robinson,et al.  Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. , 1990, Reviews of infectious diseases.

[14]  T. Walsh,et al.  Pharmacokinetics and tissue penetration of fluconazole in rabbits , 1989, Antimicrobial Agents and Chemotherapy.

[15]  D. Weidler,et al.  Steady State Parenteral Kinetics of Fluconazole in Man , 1988, Annals of the New York Academy of Sciences.

[16]  A. Catanzaro,et al.  Fluconazole Penetration into Cerebrospinal Fluid in Humans , 1988, Journal of clinical pharmacology.

[17]  R. M. Tucker,et al.  Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis , 1988, Antimicrobial Agents and Chemotherapy.

[18]  J. Perfect,et al.  Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis , 1987, Antimicrobial Agents and Chemotherapy.

[19]  J. Perfect,et al.  Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits , 1986, Antimicrobial Agents and Chemotherapy.

[20]  M J Humphrey,et al.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.

[21]  J. Perfect,et al.  Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. , 1985, The Journal of antimicrobial chemotherapy.

[22]  J. Baum,et al.  Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis , 1981, Antimicrobial Agents and Chemotherapy.

[23]  J. Graybill,et al.  Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid , 1981, Antimicrobial Agents and Chemotherapy.

[24]  H. Akaike A new look at the statistical model identification , 1974 .

[25]  M. Sande,et al.  Effect of Probenecid on Cerebrospinal Fluid Concentrations of Penicillin and Cephalosporin Derivatives , 1974, Antimicrobial Agents and Chemotherapy.